NanoBB-1-Dox

N/A

Report date: 2025/10/27 17:55:39

Base Information

Drug NameNanoBB-1-Dox
Drug Alias Namedoxorubicin (NN Petrov Research Institute of Oncology/Univ Frankfurt)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsDNATopoisomerase II
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPetrov National Medicine Research Center of oncology
China Registration ClassN/A

Develop Information

Active CompaniesJohann Wolfgang Goethe-Universitat Frankfurt am MainPetrov National Medicine Research Center of oncology
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A